Where in the world do the Amgen jets go?
Kevin Sharer concluded his decade-long reign at the helm of the world’s largest biotechnology company on May 23, when he handed the CEO reins over to Robert Bradway. But the former chief executive of Thousand Oaks-based Amgen will continue to keep a leased office, secretary and other perks through the end of 2017, according to Read More →
Corporate close-up: A look at the region’s highest-paid public company executives
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Bloomberg: Amgen targeted in lawmakers’ probe
Thousand Oaks-based Amgen is among a handful of drugmakers being probed for more information about a deal it reached with the Obama administration to support the health care overhaul Democrats passed in 2010, according to Bloomberg News. The news agency reported on May 4 that a group of Republicans on the House Energy and Commerce Read More →
Editorial: Recognizing Rathmann, Amgen’s visionary
The co-founder of the world’s biggest biotechnology company has cast a long shadow.
Amgen to buy Turkish firm in $700M deal
Thousand Oaks-based Amgen said it will acquire Mustafa Nevzat Pharmaceuticals, a major supplier of pharmaceuticals and injectable medicines in Turkey, in a deal that values the Turkish firm at $700 million. Amgen said that its focus on Turkey and the surrounding region is part of a broad international expansion strategy for the company. Amgen established Read More →
Amgen revenue up 9 percent
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”24-10-2011″ enddate=”24-04-2012″ width=”300″ height=”245″] Amgen’s total revenue shot up 9 percent during the first quarter of this year, the Thousand Oaks-based biotech giant said in an April 24 earnings report. The biotech company reported revenue of $4 billion, up from $3.7 billion in the first quarter of 2011. Total product Read More →
